AAO News
The latest clinical breakthroughs, practice management updates, and national advocacy alerts directly from the American Academy of Ophthalmology.
Aerie Pharmaceuticals announced positive 12-month interim safety results for Rhopressa, a once-daily eye drop for patients with glaucoma or ocular hypertension.
The ArcScan Insight 100 can image and measure anterior chamber depth, angle-to-angle width, individual corneal layers and sulcus-to-sulcus width, all with micron level precision.
Six-month results from this phase 2 randomized study shows that the anti-seizure drug phenytoin protects against retinal nerve fiber layer loss in acute optic neuritis.
This retrospective study shows that illuminated microcatheter-assisted trabeculotomy can treat childhood glaucoma with a better success rate and greater IOP control compared to traditional trabeculotomy.
The early advantage aflibercept showed in treating patients with DME narrowed after 2 years of treatment, according to follow-up data from the DRCR.net Protocol T study.
Patients participating in OpenNotes demonstrated better recall of their medical plans, felt more in control of their care and were more likely to take their medications.
Our Industry Partners
Empowering Excellence in Ophthalmology
We extend our deepest gratitude to our Platinum, Gold, and Silver partners. Your generous support fuels our mission to advance medical education, advocate for patient safety, and foster breakthrough innovations across West Virginia.
West Virginia Academy of Eye Physicians and Surgeons — advancing quality eye care through education, advocacy, and community awareness.
About
Resources
Advocacy